New antibiotic could fight tough diabetic foot infections

NCT ID NCT05369052

Recruiting now Disease control Sponsor: MicuRx Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This Phase 3 trial tests a new antibiotic called contezolid against a standard one (linezolid) for moderate to severe diabetic foot infections. About 865 adults with diabetes and a foot infection will receive either drug for 2 to 4 weeks. The goal is to see if the new drug works as well or better and has fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: contezolid acefosamil (IV) and contezolid (oral)
What this could lead to: If successful, this could provide a new antibiotic option for treating serious diabetic foot infections, potentially with fewer side effects than current treatments.
What could go wrong: This is an early Phase 3 trial, so results are not yet proven. The new drug may not be more effective or safer than the existing antibiotic linezolid.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT INFECTION

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Daugavpils Regional Hospital
RECRUITING

Daugavpils, Latvia
GMV Care& Research - Maria Cecilia Hospital
RECRUITING

Cotignola, Italy
ILD Research Center
RECRUITING

Vista, California, 92081, United States
Instytut Medycyny Wsi im. W. Chodzki
RECRUITING

Lublin, Poland
JSC Vian - West Georgia Medical Center
RECRUITING

Kutaisi, Georgia
LTD High Technology Hospital Med Center
RECRUITING

Batumi, Georgia
MHAT Sveti Nikolay Chudotvorets EOOD
RECRUITING

Lom, Bulgaria
Medical Institute Ministry of Interior Central Clinical Base
RECRUITING

Sofia, Bulgaria
Multiprofile Hospital for Active Treatment - KANEV
RECRUITING

Rousse, Bulgaria
New Hope Research Development
RECRUITING

Corona, California, 92882, United States
PODEMA Sp. z o.o.
RECRUITING

Warsaw, Poland
South-Estonian Hospital Ltd.
RECRUITING

Võru, Estonia
University Clinical Center Kragujevac
RECRUITING

Kragujevac, Serbia
University Multidisciplinary Hospital for Active Treatment and Emergency Medicine 'N. I. Priogov´
RECRUITING

Sofia, Bulgaria

More trials for these conditions

Other studies related to the condition(s) this trial covers.